Chemically programmed antibodies targeting multiple alpha(v) integrins and their effects on tumor-related functions in vitro

Bioconjugate Chemistry

Volumn 22, Issue 8, 2011, Pages 1535-1544

  Goswami, Rajib K ^a   Bajjuri, Krishna M ^a   Forsyth, Jane S ^b   Das, Sanjib ^a,c   Hassenpflug, Wolf ^b   Huang, Zheng Zheng ^a,d   Lerner, Richard A ^a   Felding Habermann, Brunhilde ^b   Sinha, Subhash C ^a  

^a Department of Molecular Biology ^*  (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c Glenmark Pharmaceuticals Limited   (India)

^d DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELL ADHESION; CELL CULTURE; CELLS; DISEASES; LIGANDS; TUMORS;

CELLULAR FUNCTION; HUMAN CANCER; IN-VITRO; IN-VIVO; INTEGRINS; OSTEOPONTIN; RELATED FUNCTIONS; TUMOR PROGRESSIONS; TUMOR VASCULATURE; TUMOUR CELLS;

GLYCOPROTEINS;

ALPHAVBETA6 INTEGRIN; ANTIBODY; CD51 ANTIGEN; FIBRONECTIN; FRUCTOSE BISPHOSPHATE ALDOLASE; OSTEOPONTIN; PROTEIN INHIBITOR; VITRONECTIN RECEPTOR;

ANGIOGENESIS; ANTIBODY AFFINITY; ANTIBODY LIBRARY; ANTIGEN BINDING; ARTICLE; CANCER CELL CULTURE; CATALYSIS; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TUMOR; TUMOR CELL; TUMOR GROWTH; VASCULARIZATION;

EID: 80051715566     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc2000879     Document Type: Article

References (46)

1. Caswell, P. T., Vadrevu, S., and Norman, J. C. (2009) Integrins: masters and slaves of endocytic transport Nat. Rev. Mol. Cell Biol. 10, 843-853
2. Shattil, S. J., Kim, C., and Ginsberg, M. H. (2010) The final steps of integrin activation: the end game Nat. Rev. Mol. Cell Biol. 11, 288-300
3. Desgrosellier, J. S. and Cheresh, D. A. (2010) Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 10, 9-22
4. Cox, D., Brennan, M., and Moran, N. (2010) Integrins as therapeutic targets: lessons and opportunities Nat. Rev. Drug Discovery 9, 804-820
5. van der Flier, A., Badu-Nkansah, K., Whittaker, C. A., Crowley, D., Bronson, R. T., Lacy-Hulbert, A., and Hynes, R. O. (2010) Endothelial α5 and αv integrins cooperate in remodeling of the vasculature during development Development 137, 2439-2449
6. Erdreich-Epstein, A., Shimada, H., Groshen, S., Liu, M., Metelitsa, L. S., Kim, K. S., Stins, M. F., Seeger, R. C., and Durden, D. L. (2000) Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide Cancer Res. 60, 712-721 (Pubitemid 30094572)
7. Koopman Van Aarsen, L. A., Leone, D. R., Ho, S., Dolinski, B. M., McCoon, P. E., LePage, D. J., Kelly, R., Heaney, G., Rayhorn, P., Reid, C., Simon, K. J., Horan, G. S., Tao, N., Gardner, H. A., Skelly, M. M., Gown, A. M., Thomas, G. J., Weinreb, P. H., Fawell, S. E., and Violette, S. M. (2008) Antibody-mediated blockade of integrin αvβ6 inhibits tumor progression in vivo by a transforming growth factor-B-regulated mechanism Cancer Res. 68, 561-570 (Pubitemid 351380085)
8. Breuss, J. M., Gallo, J., DeLisser, H. M., Klimanskaya, I. V., Folkesson, H. G., Pittet, J. F., Nishimura, S. L., Aldape, K., Landers, D. V., and Carpenter, W. (1995) Expression of the β6 subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling J. Cell. Sci. 108, 2241-2251
9. Jones, J., Watt, F. M., and Speight, P. M. (1997) Changes in the expression of alpha v integrins in oral squamous cell carcinomas J. Oral Pathol. Med. 26, 63-68 (Pubitemid 27157727)
10. Hakkinen, L., Hildebrand, H. C., Berndt, A., Kosmehl, H., and Larjava, H. (2000) Immunolocalization of tenascin-C, α9 integrin subunit, and αvβ6 integrin during wound healing in human oral mucosa J. Histochem. Cytochem. 48, 985-998 (Pubitemid 30421563)
11. Regezi, J. A., Ramos, D. M., Pytela, R., Dekker, N. P., and Jordan, R. C. K. (2002) Tenascin and β6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas Oral Oncol. 38, 332-336 (Pubitemid 34655686)
12. Ahmed, N., Pansino, F., Baker, M., Rice, G., and Quinn, M. (2002) Association between αvβ6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation on ovarian cancer J. Cell. Biochem. 84, 675-686 (Pubitemid 34113107)
13. Bates, R. C., Bellovin, D. I., Brown, C., Maynard, E., Wu, B., Kawakatsu, H., Sheppard, D., Oettgen, P., and Mercurio, A. M. (2005) Transcriptional activation of integrin β6 during the epithelialmesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma J. Clin. Invest. 115, 339-347 (Pubitemid 40385475)
14. Hazelbag, S., Kenter, G., Gorter, A., Dreef, E., Koopman, L., Violette, S., Weinreb, P., and Fleuren, G. (2007) Overexpression of the αvβ6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival J. Pathol. 212, 316-324 (Pubitemid 47010065)
15. Lafrenie, R. M., Buckner, C. A., and Bewick, M. A. (2007) Cell adhesion and cancer: is there a potential for therapeutic intervention? Expert Opin. Ther. Targeting 11, 727-731 (Pubitemid 46908269)
16. Rader, C., Sinha, S. C., Popkov, M., Lerner, R. A., and Barbas, C. F., III (2003) A chemically programmed monoclonal antibody for cancer therapy Proc. Natl. Acad. Sci. U.S.A. 100, 5396-5400
17. Li, L.-S., Rader, C., Matsushita, M., Das, S., Barbas, C. F., III, Lerner, R. A., and Sinha, S. C. (2004) Chemical-adaptor immunotherapy: design, synthesis and evaluation of novel integrin-targeting devices J. Med. Chem. 47, 5630-5640 (Pubitemid 39447260)
18. Rader, C., Turner, J. M., Heine, A., Shabat, D., Sinha, S. C., Wilson, I. A., Lerner, R. A., and Barbas, C. F., III (2003) A humanized aldolase antibody for selective chemotherapy and adaptor immunotherapy J. Mol. Biol. 332, 889-899 (Pubitemid 37101375)
19. Guo, F., Das, S., Mueller, B. M., Barbas, C. F., III, Lerner, R. A., and Sinha, S. C. (2006) Breaking the one antibody-one target axiom Proc. Natl. Acad. Sci. U.S.A. 103, 11009-11014 (Pubitemid 44148409)
20. Goswami, R. K., Huang, Z.-Z., Forsyth, J. S., Felding-Habermann, B., and Sinha, S. C. (2009) Multiple catalytic aldolase antibodies suitable for chemical programming Bioorg. Med. Chem. Lett. 19, 3821-3824
21. Gavrilyuk, J. I., Wuellner, U., Salahuddin, S., Goswami, R. K., Sinha, S. C., and Barbas, C. F., III (2009) An efficient chemical approach to bispecific antibodies and antibodies of high valency Bioorg. Med. Chem. Lett. 19, 3716-3720
22. Wagner, J., Lerner, R. A., and Barbas, C. F., III (1995) Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes Science 270, 1797-1800 (Pubitemid 26007222)
23. Zhong, G., Lerner, R. A., and Barbas, C. F., III (1999) Broadening the aldolase catalytic antibody repertoire by combining reactive immunization and transition state theory: new enantio- and diastereoselectivities Angew. Chem., Int. Ed. 38, 3738-3741 (Pubitemid 30022002)
24. Popkov, M., Rader, C., Gonzalez, B., Sinha, S. C., and Barbas, C. F., III (2006) Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector Int. J. Cancer 119, 1194-1207 (Pubitemid 44116929)
25. Doppalapudi, V. R., Tryder, N., Li, L., Aja, T., Griffith, D., Liao, F.-F., Roxas, G., Ramprasad, M. P., Bradshaw, C., and Barbas, C. F. (2007) Chemically programmed antibodies: endothelin receptor targeting CovX-bodies Bioorg. Med. Chem. Lett. 17, 501-506 (Pubitemid 46073729)
26. Doppalapudia, V. R., Huanga, J., Liua, D., Jina, P., Liua, B., Lia, L., Desharnaisa, J., Hagena, C., Levina, N. J., Shieldsa, M. J., Parisha, M., Murphya, R. E., Del Rosarioa, J., Oatesa, B. D., Laia, J.-Y., Matina, M. J., Ainekulua, Z., Bhata, A., Bradshawa, C. W., Woodnutta, G., Lerner, R. A., and Lappe, R. W. (2010) Chemical generation of bispecific antibodies Proc. Natl. Acad. Sci. U.S.A. 107, 22611-22616
27. Felding-Habermann, B., Mueller, B. M., Romerdahl, C. A., and Cheresh, D. A. (1992) Involvement of integrin αv gene expression in human melanoma tumorigenicity J. Clin. Invest. 89, 2018-2022
28. Rolli, M., Fransvea, E., Pilch, J., Saven, A., and Felding-Habermann, B. (2003) Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 100, 9482-9487 (Pubitemid 37033954)
29. Wayner, E. A., Orlando, R. A., and Cheresh, D. A. (1991) Integrins alpha v beta 3 and alpha v beta 5 contribute to cell attachment to vitronectin but differentially distribute on the cell surface J. Cell Biol. 113, 919-929 (Pubitemid 21909725)
30. Alkhalaf, M. and Jaffal, S. (2006) Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: novel cellular mechanism involving the ERKs/p53 cascade Free Radical Biol. Med. 41, 318-325 (Pubitemid 43928507)
31. Lidor, Y. J., Shpall, E. J., Peters, W. P., and Bast, R. C., Jr. (1991) Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer Int. J. Cancer 49, 704-710
32. Weinreb, P. H., Simon, K. J., Rayhorn, P., Yang, W. J., Leone, D. R., Dolinski, B. M., Pearse, B. R., Yokota, Y., Kawakatsu, H., Atakilit, A., Sheppard, D., and Violette, S. M. (2004) Function-blocking integrin αvβ6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes J. Biol. Chem. 279, 17875-17887 (Pubitemid 38560556)
33. Cambier, S., Mu, D.-Z., O'Connell, D., Boylen, K., Travis, W., Liu, W.-H., Broaddus, V. C., and Nishimura, S. L. (2000) A Role for the Integrin αvβ8 in the Negative Regulation of Epithelial Cell Growth Cancer Res. 60, 7084-7093 (Pubitemid 32059188)
34. Rodionov, V. M. and Postovskaja, E. A. (1929) Mechanism of formation of β-aryl-β-amino fatty acids by the condensation of aroatic aldehydes with malonic acid and its derivatives J. Am. Chem. Soc. 51, 841-847
35. Johnson, T. B. and Livak, J. E. (1936) Pyrimidines. CXLIX. The synthesis of aryl-substituted dihydrouracils and their conversion into uracil derivatives J. Am. Chem. Soc. 58, 299-303
36. Miyaura, N. and Suzuki, A. (1995) Palladium-catalyzed cross-coupling reactions of organoboron compounds Chem. Rev. 95, 2457-2483
37. Sinha, S. C., Das, S., Li, L.-S., Lerner, R. A., and Barbas, C. F., III (2007) Preparation of integrin alpha(v)beta(3)-targeting Ab 38C2 constructs Nat. Prot. 2, 449-456 (Pubitemid 47040060)
38. Zhu, X., Tanaka, F., Lerner, R. A., Barbas, C. F., III, and Wilson, I. A. (2009) Direct observation of an enamine intermediate in amine catalysis J. Am. Chem. Soc. 131, 18206-18207
39. List, B., Barbas, C. F., III, and Lerner, R. A. (1998) Aldol sensors for the rapid generation of tunable fluorescence by antibody catalysis Proc. Natl. Acad. Sci. U.S.A. 95, 15351-15355 (Pubitemid 29018702)
40. Goodman, S. L., Hölzemann, G., Sulyok, G. A. G., and Kessler, H. (2002) Nanomolar small molecule inhibitors for αvβ6, αvβ5 and αvβ3 integrins J. Med. Chem. 45, 1045-1051 (Pubitemid 34173914)
41. Simoni, D., Rondanin, R., Baruchello, R., Rizzi, M., Grisolia, G., Eleopra, M., Grimaudo, S., Di Cristina, A., Pipitone, M. R., Bongiorno, M. R., Arico, M., Invidiata, F. P., and Tolomeo, M. (2008) Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptopic properties J. Med. Chem. 51, 4796-4803
42. Li, E., Brown, S. L., Stupack, D. G., Puente, X. S., Cheresh, D. A., and Nemerow, G. R. (2001) Integrin αvβ1 Is an Adenovirus Coreceptor J. Virol. 75, 5405-5409
43. Humphries, J. D., Byron, A., and Humphries, M. J. (2006) Integrin ligands at a glance J. Cell Sci. 119, 3901-3903 (Pubitemid 44650863)
44. Humphries, M. J. (2004) Monoclonal antibodies as probes of integrin priming and activation Biochem. Soc. Trans. 32, 407-411 (Pubitemid 38813525)
45. Kok, R. J., Schraa, A. J., Bos, E. J., Moorlag, H. E., Ásgeirsdóttir, S. A., Everts, M., Meijer, D. K. F., and Molema, G. (2002) Preparation and functional evaluation of RGD-modified proteins as αvβ3 integrin directed therapeutics Bioconjugate Chem. 13, 128-135 (Pubitemid 34119644)
46. Shin, I. S., Jang, B.-S., Danthi, S. N., Xie, J., Yu, S., Le, N., Maeng, J.-S., Hwang, I. S., Li, K. C. P., Carrasquillo, J. A., and Paik, C. H. (2007) Use of antibody as carrier of oligomers of peptidomimetic αvβ3 antagonist to target tumor-induced neovasculature Bioconjugate Chem. 18, 821-828 (Pubitemid 47010803)